Skip to main content
Harbin Pharmaceutical Group Co.,Ltd. logo

Harbin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 600664 ISIN · CNE0000009T3 LEI · 300300G0L086UJ23MI26 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,827 across all filing types
Latest filing 2015-09-15 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600664

About Harbin Pharmaceutical Group Co.,Ltd.

https://www.hayao.com/

Harbin Pharmaceutical Group Co., Ltd. specializes in the research, development, manufacture, and distribution of a diverse range of pharmaceutical and healthcare products. The company's portfolio includes antibiotics, over-the-counter (OTC) medicines, health supplements, traditional Chinese medicines, and animal health products. It operates through several specialized subsidiaries and maintains a significant presence in the production of penicillins and cephalosporins. A key strategic focus involves the health and nutrition sector, bolstered by the acquisition of global nutrition brand GNC. The company leverages large-scale manufacturing capabilities and an extensive distribution network to serve both domestic and international markets. Its operations emphasize technological innovation and quality control across its integrated supply chain, from raw material production to finished dosage forms.

Recent filings

Filing Released Lang Actions
2015年第二次临时股东大会之法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2015 second extraordinary general meeting (临时股东大会) of 哈药集团股份有限公司. It details the procedures of convening and holding the meeting, qualifications of attendees, voting procedures, and the voting results. The document focuses on the legality and validity of the meeting and its resolutions, not on financial results or management reports. It is not a full annual or interim report, nor an earnings release or investor presentation. It is also not a proxy solicitation or voting results announcement alone, but a legal opinion on the meeting's conduct and results. This type of document is best classified under Regulatory Filings (RNS) as it is a compliance/legal procedural filing related to a shareholder meeting, without being the meeting materials themselves or the voting results announcement alone.
2015-09-15 Chinese
关于控股股东增持本公司股票的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a public announcement regarding the progress of the controlling shareholder's increase in shareholding in the company. It details the number of shares purchased, the percentage of total shares held before and after the increase, and the future plan for further share purchases. There is no financial report, earnings data, or management discussion. The document is a formal disclosure of a transaction involving the company's own shares by a major shareholder. This fits the category of 'Transaction in Own Shares' (POS), which covers reports of the company or its controlling shareholders buying back or increasing their holdings of the company's shares.
2015-09-15 Chinese
2015年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement from a 2015 second extraordinary shareholders' meeting (临时股东大会决议公告). It details the meeting date, attendance, voting results on profit distribution, and legal verification of the meeting process. It does not contain financial statements or detailed financial analysis but reports the official voting results and resolutions passed at the shareholders' meeting. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (1941 characters) and is a formal announcement of voting results, not a full report or presentation.
2015-09-15 Chinese
关于控股股东增持本公司股票的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the controlling shareholder increasing their shareholding in the company. It details the number of shares purchased, the percentage of total shares held before and after the purchase, and future plans for additional share purchases. It also includes legal compliance statements and commitments related to the shareholding. There is no financial report, earnings data, or management discussion. This fits the definition of a 'Major Shareholding Notification' (MRQ), which covers notifications of changes in significant share ownership levels.
2015-09-07 Chinese
2015年第二次临时股东大会会议材料
AGM Information Classification · 95% confidence The document is titled as materials for the 2015 second extraordinary shareholders' meeting of Harbin Pharmaceutical Group Co., Ltd. It includes meeting instructions, agenda, voting methods, and a specific proposal regarding the 2015 half-year profit distribution. The content is focused on the meeting process and the proposal for dividend distribution, which is typical for shareholder meeting materials. The document length is 1921 characters, which is relatively short and consistent with meeting materials rather than a full report. There is no detailed financial statement or comprehensive analysis, so it is not an Interim/Quarterly Report (IR) or Annual Report (10-K). It is not a voting result announcement (DVA) because it does not provide the results, only the agenda and proposal. Therefore, the document fits best as AGM Information (AGM-R), which covers presentations and materials shared during the Annual or Extraordinary General Meeting.
2015-09-02 Chinese
关于召开2015年第二次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about the convening of the 2015 second extraordinary general meeting of shareholders (临时股东大会) for 哈药集团股份有限公司. It includes details about the meeting date, voting methods, agenda items (such as profit distribution for the half-year 2015), voting procedures, and proxy authorization forms. There is no financial data or report content, only an announcement of the meeting and related procedural information. The document length is 2683 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document is best classified as a Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings.
2015-08-30 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.